Skip to content
Governance Register

← US public companies

Phathom Pharmaceuticals, Inc.

SEC CIK 1783183 · PHAT · last insider filing 2026-05-27

Directors (from insider filings)

NameCapacity as filedFilings
Parikh Asit Director filed 2019 - 2026
Kunz Heidi Director filed 2019 - 2026
Cola Michael F Director filed 2019 - 2026
Karbe Frank Director filed 2022 - 2026
Topper James N Director filed 2019 - 2026
Schroeder Theodore R Director filed 2025 - 2026
Stenhouse Mark Director filed 2020 - 2026
Basta Steven L Director · President and CEO filed 2025 - 2026
Curran Terrie Director · President and Chief Executive filed 2019 - 2025
Socks David A Director · President, CEO, Treas. & Sec. filed 2019 - 2024
Yamada Tadataka Director filed 2019 - 2021
Edwards Jonathan S. Director filed 2019 - 2019
Slavinsky Christopher W. Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Breedlove Robert Charles Principal Accounting Officer filed 2025 - 2026
Cook Anne Marie Chief Legal Off. & Corp. Sec. filed 2025 - 2026
Narula Sanjeev Chief Financial & Bus. Officer filed 2025 - 2026
Henderson Molly CFO and CBO filed 2022 - 2025
Nabulsi Azmi Chief Operating Officer filed 2019 - 2025
Guzzo Anthony J. VP, Chief Accounting Officer filed 2021 - 2022
Branning Todd P. Chief Financial Officer filed 2020 - 2021
Kohli Aditya Chief Business Officer filed 2019 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.